Mostrando 10 resultados de: 13
Filtros aplicados
Subtipo de publicación
Article(13)
Área temáticas
Enfermedades(11)
Problemas sociales y servicios a grupos(5)
Farmacología y terapéutica(2)
Cirugía y especialidades médicas afines(1)
Economía(1)
Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data
ArticleAbstract: Background Hypertension is considered the most important risk factor for cardiovascular diseases, buPalabras claves:Autores:Agapay D., Alhabib K.F., Aliberti A., Aoucheva N., Attaei M.W., Auger D., Avezum A.J., Azad A.K., Bahonar A., Casaccia G., Casanova A., Cherry H.M., Chin S.L., Choudhury T., Chow C.K., Dagenais G.R., Dayal L., Dehghan M., Dejesus J., Devanath A., DIaz R., Elsheikh W., Gupta R., Hall K., Haque R., Hari D., Hassan I., Heldman L., Hu W., Hussain F., Igumbor E.U., Islam S., Joseph P.G., Kandy N., Kaur M., Kay I., Keneth J., Keys J., Khan M.U., Khatib R., Kruger L., Kutty R., Lanas F.T., Lear S.A., Leong D.P., Lewis B.S., Lewis G., Lindeman J., Linetsky B., Mackie P., Maini Cuneo J.M., Mannan A., Marcilio C.S., Mattos A.C., Mckee M., McQueen M.J., Mente A., Milazzo E., Mohan V., Mushtaha M., Oguz A., Oliveira G.B.F., Orlandini A., O’Donnell M., Parvin S., PATRICIO LOPEZ -JARAMILLO, Poirier P., Rabbani K.A., Rahman O., Ramacham S., Ramasundarahettige C., Ramezani E., Rangarajan S., Reyes A., Rimac J., Rosengren A., Shahrook S., Shifaly F., Sintaha M., Smyth A., Solano R., Swallow J., Szuba A., Talukdar A.T., Teo K.K., Tongana T., Tooheen R.B., Toscanelli S., Trottier M., Trottier S., Turbide G., Wang X., Wong G.W.K., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M., Zaki A., Zhang B., Zhang M.Fuentes:googlescopusAlcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: A prospective cohort study
ArticleAbstract: Summary Background Alcohol consumption is proposed to be the third most important modifiable risk faPalabras claves:Autores:Avezum A.J., Chifamba J., Dagenais G.R., DIaz R., Jian B., Kumar R., Lear S.A., Leong D.P., Mckee M., Mohan V., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rana P., Rangarajan S., Rosengren A., Schutte A.E., Seron P., Smyth A., Szuba A., Teo K.K., Wei L., Yang W., Yusuf S., Zhang X.Fuentes:googlescopusModifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
ArticleAbstract: Background: Global estimates of the effect of common modifiable risk factors on cardiovascular diseaPalabras claves:Autores:Alhabib K.F., Avezum A.J., Bo H., Brauer M., Chifamba J., Dagenais G.R., Dans A.M., DIaz R., Gupta R., Hystad P., Iqbal R., Islam S., Joseph P.G., Kaur M., Kelishadi R., Khatib R., Kruger L., Kutty V.R., Lanas F.T., Lear S.A., Leong D.P., Mckee M., Mente A., Mohan V., Mony P.K., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rahman O., Rangarajan S., Rosengren A., Teo K.K., Wei L., Wielgosz A., Yeates K.E., Yusoff K., Yusuf S., Yusufali A.M., Zatońska K.Fuentes:googlescopusPeripheral Blood MCEMP1 Gene Expression as a Biomarker for Stroke Prognosis
ArticleAbstract: A limitation when making early decisions on stroke management is the lack of rapid diagnostic and prPalabras claves:Biomarkers, Blood, gene expression profiling, prognosis, strokeAutores:Czlonkowska A., O’Donnell M., Paré G., PATRICIO LOPEZ -JARAMILLO, Peñaherrera E., Raman K., Sharma M., Shoamanesh A., Skowronska M., Yan Duarte, Yusuf S.Fuentes:googlescopusSafety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
ArticleAbstract: Background & Aims: Proton pump inhibitors (PPIs) are effective at treating acid-related disorders. TPalabras claves:bacteria, CVD, Reflux, ThrombosisAutores:Alings M., Anand S.S., Avezum A.J., Bhatt D.L., Bosch J.J., Branch K.R.H., Bruns N.C., Commerford P.J., Connolly S.J., Dagenais G.R., Dans A.M., DIaz R., Dyal L., Eikelboom J.W., Ertl G., Felix Camilo, Fox K.A.A., Guzik T.J., Hart R.G., Hori M., Kakkar A.K., Keltai M., Kim J.H., Lanas F.T., Leong D.P., Lewis B.S., Liang Y., Lonn E.M., Maggioni A.P., Metsarinne K.P., Moayyedi P., Muehlhofer E., O’Donnell M., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Shestakovska O., Steg P.G., Störk S., Tonkin A.M., Torp-Pedersen C., Verhamme P.B., Vinereanu D., Widimsky P., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusVariations in knowledge, awareness and treatment of hypertension and stroke risk by country income level
ArticleAbstract: Objective Hypertension is the most important modifiable risk factor for stroke globally. We hypothesPalabras claves:epidemiology, Hypertension, strokeAutores:Alhussain F., Avezum A.J., Chin S.L., Czlonkowska A., Daliwonga M., Damasceno A., Dans A.M., DIaz R., Diener H.C., ElSayed A., Ferguson J., Hankey G.J., Iqbal R., Iversen H.K., Judge C., Lanas F.T., Langhorne P., Lisheng L., Málaga G., Mondo C.K., Nilanont Y., Ogah O.S., Ogunniyi A., Oguz A., Oveisgharan S., O’Donnell M., Pais P., PATRICIO LOPEZ -JARAMILLO, Peñaherrera E., Pogosova N., Rangarajan S., Rao-Melacini P., Rosengren A., Rumboldt Z., Ryglewicz D., Smyth A., Wang X., Weimar C., Xavier D., Yusoff K., Yusuf S., Yusufali A.M., Zhang H.Fuentes:googlescopusRationale and design of interstroke: A global case-control study of risk factors for stroke
ArticleAbstract: Stroke is a major global health problem. It is the third leading cause of death and the leading causPalabras claves:International case-control study, RISK FACTORS, strokeAutores:Avezum A.J., Chin S.L., Czlonkowska A., Damasceno A., Dans T., Devilliers L., DIaz R., Diener H.C., Hankey G.J., Kapral M., Lanas F., Langhorne P., Liu L., Mondo C.K., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Pias P., Rangarajan S., Ryglewicz D., Sacco R.L., Skowronska M., Teal P., Truelsen T., Varigos J.D., Xavier D., Yusuf S., Zhang H.Fuentes:googlescopusRationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial
ArticleAbstract: Background Long-term aspirin prevents vascular events but is only modestly effective. Rivaroxaban alPalabras claves:Autores:Aboyans V., Alings M., Anand S.S., Avezum A.J., Bhatt D.L., Bosch J.J., Branch K.R.H., Bruns N.C., Chen E., Commerford P.J., Connolly S.J., Dagenais G.R., Dans A.M., DIaz R., Eikelboom J.W., Ertl G., Felix Camilo, Fox K.A.A., Guzik T.J., Ha J.W., Hart R.G., Hori M., Kakkar A.K., Keltai K., Keltai M., Kim J.H., Lamy A., Lanas F., Lanius V., Leong D.P., Lewis B.S., Liang Y., Liu L., Lonn E.M., Maggioni A.P., Metsarinne K.P., Misselwitz F., Moayyedi P., O’Donnell M., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Sharma M., Steg P.G., Störk S., Tonkin A.M., Torp-Pedersen C., Varigos J.D., Verhamme P.B., Vinereanu D., Widimsky P., Yuan F., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusRationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial
ArticleAbstract: Background: Covert vascular disease of the brain manifests as infarcts, white matter hyperintensitiePalabras claves:Anticoagulant, Clinical trial, COGNITION, magnetic resonance imaging, prevention, silent infarctAutores:Avezum A.J., Berkowitz S.D., Bhatt D.L., Bosch J.J., Branch K.R.H., Casanova A., Connolly S.J., Cook-Bruns N., Dagenais G.R., DIaz R., Eikelboom J.W., Ertl G., Fox K.A.A., Ha J.W., Hart R.G., Keltai K., Keltai M., Kim J.H., Liang Y., Liu L., Lonn E.M., Maggioni A.P., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Sharma M., Smith E.E., Störk S., Tonkin A.M., Varigos J.D., Vinereanu D., Wong G., Yuan F., Yusuf S., Zhu J.Fuentes:googlescopusRisk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study
ArticleAbstract: Background The contribution of various risk factors to the burden of stroke worldwide is unknown, paPalabras claves:Autores:Chin S.L., Czlonkowska A., Damasceno A., Dans A.M., Denis X., Diener H.C., Hankey G.J., Islam S., Liu L., McQueen M.J., Mondo C.K., O’Donnell M., Pais P., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rao-Melacini P., Ryglewicz D., Sacco R.L., Truelsen T., Wang X., Weimar C., Yusoff K., Yusuf S., Zhang H.Fuentes:googlescopus